SOURCE: Targeted Genetics

May 01, 2008 07:30 ET

Targeted Genetics to Host Conference Call and Webcast Discussion of First Quarter Results on May 7, 2008

SEATTLE, WA--(Marketwire - May 1, 2008) - Targeted Genetics Corporation (NASDAQ: TGEN) will report its first quarter 2008 financial results before the open of the financial markets on Wednesday, May 7, 2008. Following the announcement, management will host a conference call and webcast discussion of the financial results and provide a general corporate update beginning at 10:30 a.m. Eastern Time / 7:30 a.m. Pacific Time. You may access the live webcast via the "Events" section found on the homepage of the Company's website at or via telephone at 800.257.7063 (domestic) or 303.262.2125 (international).

Replay Access

Webcast replay will be available for approximately 30 days at; telephone replay will be available following Wednesday's call at approximately 10:30 a.m. PT through 11:59 p.m. PT, Saturday, June 7, 2008, by calling 800.405.2236 (domestic) or 303.590.3000 (international); pass code 11112898#.

About Targeted Genetics

Targeted Genetics Corporation is a biotechnology company committed to the development of innovative targeted molecular therapies for the prevention and treatment of acquired and inherited diseases with significant unmet medical need. Targeted Genetics' proprietary Adeno-Associated Virus (AAV) technology platform allows it to deliver genes that encode proteins to increase gene function or RNAi to decrease or silence gene function. Targeted Genetics' product development efforts target inflammatory arthritis, AIDS prophylaxis, congestive heart failure and Huntington's disease. To learn more about Targeted Genetics, visit Targeted Genetics' website at

Contact Information

  • Investor and Media Contacts:
    Stacie D. Byars
    Senior Associate
    WeissComm Partners

    Carolyn Wang
    Senior Associate
    WeissComm Partners